Clinical Trial Update: PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial (PRO-BOOST-N) evaluating Prostate-First versus combined Prostate and nodal dose escalation in PSMA PET-staged node-positive pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy | Conditions: Prostate Cancer, Brachytherapy | Phase 2, Phase 3 | Status: RECRUITING